Information Provided By:
Fly News Breaks for December 16, 2016
RGLS
Dec 16, 2016 | 05:50 EDT
Cantor Fitzgerald analyst William Tanner started Regulus Therapeutics with an Overweight rating and $11 price target.
News For RGLS From the Last 2 Days
There are no results for your query RGLS